Moreover, co-delivery of constitutively active PRRs, such as a mutant STING, enhanced activation of vaccine antigen target HPV E7–specific CD8+ effector memory T cells in mice, leading to improved control of tumor growth (83). This evidence concerns the gene CD8A and neoplasm.